Lenvatinib acts as the salvage therapy for advanced hepatocellular carcinoma

被引：0
|
作者：
Hsieh, M-C. [1 ]
Su, Y-L. [2 ]
Chen, Y-Y. [2 ]
Liu, C-T. [2 ]
Chen, Y-H. [2 ]
Chiu, T-J. [2 ]
Pei, S-N. [3 ]
Wu, C-C. [4 ]
Rau, K-M. [1 ]
机构：
[1] E DA Canc Hosp, Oncol & Hematol, Kaohsiung, Taiwan
[2] Kaohsiung Chang Gung Mem Hosp, Oncol & Hematol, Kaohsiung, Taiwan
[3] Chiayi Chang Gung Mem Hosp, Oncol & Hematol, Chiayi, Taiwan
[4] Chang Gung Mem Hosp Kaohsiung, Internal Med, Kaohsiung, Taiwan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
182P
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [1] Overview of lenvatinib as a targeted therapy for advanced hepatocellular carcinoma
    Rehman, Obaid
    Jaferi, Urooj
    Padda, Inderbir
    Khehra, Nimrat
    Atwal, Harshan
    Mossabeh, Dina
    Bhangu, Ranvir
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 7 (03) : 249 - 257
  • [2] Lenvatinib in Advanced Hepatocellular Carcinoma
    Kudo, Masatoshi
    LIVER CANCER, 2017, 6 (04) : 253 - 263
  • [3] Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma
    Bedrose, Sara
    Miller, Kevin Charles
    Altameemi, Lina
    Ali, Mohamed S.
    Nassar, Sameh
    Garg, Naveen
    Daher, Marilyne
    Eaton, Keith D.
    Yorio, Jeffrey Thomas
    Daniel, Davey B.
    Campbell, Matthew
    Bible, Keith C.
    Ryder, Mabel
    Chintakuntlawar, Ashish, V
    Habra, Mouhammed Amir
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [4] Lenvatinib as a therapy for unresectable hepatocellular carcinoma
    Spallanzani, Andrea
    Orsi, Giulia
    Andrikou, Kalliopi
    Gelsomino, Fabio
    Rimini, Margherita
    Riggi, Laura
    Cascinu, Stefano
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (11) : 1069 - 1076
  • [5] Lenvatinib: a potential breakthrough in advanced hepatocellular carcinoma?
    Oikonomopoulos, Georgios
    Aravind, Preetha
    Sarker, Debashis
    FUTURE ONCOLOGY, 2016, 12 (04) : 465 - 476
  • [6] Salvage Treatment of Nivolumab and Lenvatinib in Patients with Recurrent Hepatocellular Carcinoma
    Zhou, Lijun
    Peng, Wei
    Duan, Huaxin
    Deng, Tan
    HEPATITIS MONTHLY, 2023, 23 (01)
  • [7] Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma
    Kawamura, Yusuke
    Kobayashi, Masahiro
    Shindoh, Junichi
    Kobayashi, Yuta
    Okubo, Satoshi
    Tominaga, Licht
    Kajiwara, Akira
    Kasuya, Kayoko
    Iritani, Soichi
    Fujiyama, Shunichiro
    Hosaka, Tetsuya
    Saitoh, Satoshi
    Sezaki, Hitomi
    Akuta, Norio
    Suzuki, Fumitaka
    Suzuki, Yoshiyuki
    Ikeda, Kenji
    Arase, Yasuji
    Hashimoto, Masaji
    Kozuka, Tokuyo
    Kumada, Hiromitsu
    LIVER CANCER, 2020, 9 (06) : 756 - 770
  • [8] Combination of Lenvatinib and Proton Beam Therapy in the Management of Patients With Advanced Hepatocellular Carcinoma
    Cheng, Jen-yu
    Huang, Bing-shen
    Chen, Yen-yang
    Wang, Chih-chi
    Chen, Yen-hao
    ANTICANCER RESEARCH, 2023, 43 (03) : 1361 - 1371
  • [9] Triple combination therapy of lenvatinib, toripalimab, and hepatic arterial infusion chemotherapy versus lenvatinib for advanced hepatocellular carcinoma
    Lai, Z-C.
    He, M-K.
    Shi, M.
    Li, Q-J.
    ANNALS OF ONCOLOGY, 2020, 31 : S1306 - S1306
  • [10] Colitis induced by Lenvatinib in a patient with advanced hepatocellular carcinoma
    Miyajima, Saori
    Tsuji, Kunihiro
    Kito, Yosuke
    Yoshida, Naohiro
    Matsunaga, Kazuhiro
    Tsuji, Shigetsugu
    Katayanagi, Kazuyoshi
    Yonezawa, Miwa
    Kubo, Anna
    Ushijima, Kahori
    Minato, Hiroshi
    Doyama, Hisashi
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2021, 14 (01) : 187 - 192
12345